Dr. Reddys Laboratories Limited (nyse:RDY) is set to announce first quarter earning results on Wednesday 29th July 2020, before market open.
Previous Quarter Performance
Dr. Reddys Laboratories Limited posted income for the fourth quarter of $ 0.61 per share, from the revenue of $ 588.00 million. The quarterly earnings dropped 58.33 percent while revenues compared with the same quarter last year. According to street consensus, revenue of was expected for the fourth quarter The top line results analysts by $ 51.00 million or .
Historical Earnings Performance
wpDataChart with provided ID not found! wpDataTable with provided ID not found!Click Here For More Historical Earnings Of Dr. Reddys Laboratories Limited
Conference Call
Dr. Reddys Laboratories Limited will be hosting a conference call at 8:00 AM eastern time on 29th July 2020, to discuss its 1Q21 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.drreddys.com
Dr. Reddys Laboratories Limited operates as an integrated pharmaceutical company worldwide. It operates through three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products.
